FolioLanternBeta
INFQInfleqtion, Inc.

David Singer

Director at Infleqtion, Inc., as of May 29, 2026Sold $256M of stock in the past 12 months: 100% with no plan disclosed.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
16.35M
shares sold, past 12 months
4
days with sales
$92.1M
largest single day, May 21, 2026
2
companies filed for

Share of stake sold and shares held at Infleqtion, Inc. are not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMay 2026: $256M no plan disclosed$256MMayJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Infleqtion, Inc. (INFQ)DirectorFeb 18, 2026May 29, 2026
Corcept Therapeutics Inc (CORT)Former DirectorApr 14, 2004Feb 13, 2008

Also a director at

Corcept Therapeutics Inc (CORT) (no filing in the last 18 months)

Recent filings

The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.